Scientific Advisory Council

Charles G. Drake, MD, PhD

NewYork-Presbyterian / Columbia University Medical Center

New York, NY

Dr. Charles G. Drake is the director of genitourinary oncology, the co-director of the Cancer Immunotherapy Program, and the associate director for clinical research at NewYork-Presbyterian / Columbia University Medical Center.

Dr. Drake’s areas of expertise include immunotherapy and the diagnosis and treatment of cancers of the prostate, kidney, bladder, and testes. He’s shown how targeting the immune checkpoint LAG-3 can improve the effectiveness of anti-cancer immune responses, and that it works well in combination with anti-PD-1 immunotherapy. He also continues to explore how we can improve the ability of anti-cancer T cells to eliminate tumors.

In addition to being a member of CRI’s Scientific Advisory Council, Dr. Drake serves on the CLIP Grant Review Committee.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.